Description

4-[3-(2,3-Dihydro-1,4-Benzodioxin-2-Yl)[1,2,4]Triazolo[3,4-B][1,3,4]Thiadiazol-6-Yl]-2-Methylquinoline is a high-purity, advanced heterocyclic compound designed for specialized research and development applications. This complex molecule, with CAS NO 954837-73-1, serves as a critical pharmacological research intermediate and a versatile building block in organic synthesis. It is primarily utilized by pharmaceutical R&D teams and agrochemical innovators seeking to develop novel active ingredients.

Application

This specialized chemical finds its primary utility in advanced research and development sectors. Key application areas include:

• Pharmaceutical Intermediate: Serves as a key precursor in the synthesis of novel drug candidates, particularly for central nervous system (CNS) and anti-infective therapeutic areas.
• Agrochemical Research: Used as a core scaffold for developing new-generation pesticides and herbicides with targeted modes of action.
• Organic Synthesis Building Block: Employed in complex heterocyclic chemistry to construct fused ring systems for material science and chemical biology.
• Biochemical Tool Compound: Acts as a probe or inhibitor in enzymatic and receptor-binding studies within academic and industrial research laboratories.
• Material Science Research: Investigated for potential use in creating organic electronic materials due to its extended conjugated system.

Basic Information

Product Name	4-[3-(2,3-Dihydro-1,4-Benzodioxin-2-Yl)[1,2,4]Triazolo[3,4-B][1,3,4]Thiadiazol-6-Yl]-2-Methylquinoline
CAS No.	954837-73-1
Molecular Formula	C21H15N5O2S
Molecular Weight	401.44 g/mol
Synonyms	2-Methyl-4-[3-(2,3-dihydro-1,4-benzodioxin-2-yl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-6-yl]quinoline; 4-(3-(2,3-Dihydrobenzo[b][1,4]dioxin-2-yl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-6-yl)-2-methylquinoline; 954837-73-1; [1,2,4]Triazolo[3,4-b][1,3,4]thiadiazole, 6-[2-methyl-4-quinolinyl]-3-(2,3-dihydro-1,4-benzodioxin-2-yl)-; Quinoline, 4-[3-(2,3-dihydro-1,4-benzodioxin-2-yl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-6-yl]-2-methyl-
EINECS	Contact for details

Quality Control

Our production of 4-[3-(2,3-Dihydro-1,4-Benzodioxin-2-Yl)[1,2,4]Triazolo[3,4-B][1,3,4]Thiadiazol-6-Yl]-2-Methylquinoline adheres to stringent quality protocols to ensure batch-to-batch consistency and reliability for your critical research. Each lot undergoes comprehensive analytical characterization, including HPLC purity analysis, structural confirmation (NMR, MS), and impurity profiling. A detailed Certificate of Analysis (COA) is provided with every shipment, documenting all relevant specifications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Keep away from incompatible materials. For long-term storage, consider storing under an inert atmosphere to ensure optimal stability.

Specification

Item	Specification
Appearance	Off-white to light yellow crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 97.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals (as Pb)	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.